PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway

Area of Science:

• Biomedical Science
• Molecular Biology
• Cell Biology

Background:

• Inflammation is a key factor in angiogenesis, the formation of new blood vessels.
• Uncontrolled angiogenesis contributes to diseases such as cancer.
• Prostaglandin E2 (PGE2) is a pro-inflammatory molecule involved in angiogenesis via EP receptors.

Purpose of the Study:

• To investigate the role of prostaglandin E2 (PGE2) and its receptors in angiogenesis.
• To elucidate the signaling pathway downstream of EP4 involved in endothelial cell function.

Main Methods:

• In vitro endothelial cell tube formation assays.
• Ex vivo aortic ring assays and in vivo angiogenesis models.
• Use of EP subtype-selective agonists/antagonists and small interfering RNA (siRNA) for EP4 knockdown.
• Investigation of downstream signaling molecules including protein kinase A (PKA) and its substrates.

Main Results:

• PGE2 significantly promoted angiogenesis in vitro, ex vivo, and in vivo.
• EP4 receptor was identified as the primary mediator of PGE2-induced angiogenesis.
• The EP4-PKA signaling pathway, involving substrates like Rap1A, HSPB6, and endothelial NO synthase, was crucial for PGE2-mediated angiogenesis.

Conclusions:

• EP4 receptor activation by PGE2 stimulates angiogenesis through the PKA signaling pathway.
• Targeting the EP4-PKA axis presents a potential therapeutic strategy for managing pathological angiogenesis.